Clinical Trial Update: Real-World Treatment Patterns and Patient Reported Outcome in COPD (REMIND)

View source ↗

Summary

AstraZeneca-sponsored observational study in COPD reports real-world treatment patterns and patient-reported outcomes; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Snippet

Sponsor: AstraZeneca | Conditions: COPD | Status: COMPLETED